ATE205484T1 - Aminotetrazol-derivate verwendbar als stickstoff- oxid-synthase inhibitoren - Google Patents
Aminotetrazol-derivate verwendbar als stickstoff- oxid-synthase inhibitorenInfo
- Publication number
- ATE205484T1 ATE205484T1 AT95937674T AT95937674T ATE205484T1 AT E205484 T1 ATE205484 T1 AT E205484T1 AT 95937674 T AT95937674 T AT 95937674T AT 95937674 T AT95937674 T AT 95937674T AT E205484 T1 ATE205484 T1 AT E205484T1
- Authority
- AT
- Austria
- Prior art keywords
- oxide synthase
- synthase inhibitors
- nitrogen oxide
- derivatives usable
- aminotetrazole derivatives
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 3
- ULRPISSMEBPJLN-UHFFFAOYSA-N 2h-tetrazol-5-amine Chemical class NC1=NN=NN1 ULRPISSMEBPJLN-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 239000000236 nitric oxide synthase inhibitor Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- CSYSULGPHGCBQD-UHFFFAOYSA-N s-ethylisothiouronium diethylphosphate Chemical compound CCSC(N)=N.CCOP(O)(=O)OCC CSYSULGPHGCBQD-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/336,596 US5684008A (en) | 1994-11-09 | 1994-11-09 | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| PCT/US1995/014001 WO1996015120A1 (en) | 1994-11-09 | 1995-11-08 | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205484T1 true ATE205484T1 (de) | 2001-09-15 |
Family
ID=23316811
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95937674T ATE205484T1 (de) | 1994-11-09 | 1995-11-08 | Aminotetrazol-derivate verwendbar als stickstoff- oxid-synthase inhibitoren |
| AT01104598T ATE334974T1 (de) | 1994-11-09 | 1995-11-08 | Aminotetrazolderivate als stickstoffmonoxid- synthaseinhibitoren |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01104598T ATE334974T1 (de) | 1994-11-09 | 1995-11-08 | Aminotetrazolderivate als stickstoffmonoxid- synthaseinhibitoren |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US5684008A (de) |
| EP (2) | EP1113011B1 (de) |
| JP (1) | JP3278165B2 (de) |
| KR (1) | KR970707107A (de) |
| CN (1) | CN1065531C (de) |
| AT (2) | ATE205484T1 (de) |
| AU (1) | AU696527B2 (de) |
| BR (1) | BR9509629A (de) |
| CA (1) | CA2203237C (de) |
| DE (2) | DE69522703T2 (de) |
| DK (2) | DK0790987T3 (de) |
| ES (2) | ES2164164T3 (de) |
| NZ (1) | NZ296019A (de) |
| PT (2) | PT790987E (de) |
| RU (1) | RU2152927C1 (de) |
| WO (1) | WO1996015120A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5684008A (en) * | 1994-11-09 | 1997-11-04 | G. D. Searle & Co. | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| US5919940A (en) * | 1995-01-20 | 1999-07-06 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
| US5981511A (en) * | 1996-03-06 | 1999-11-09 | G.D. Searle & Co. | Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| US5945408A (en) * | 1996-03-06 | 1999-08-31 | G.D. Searle & Co. | Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors |
| US6552052B2 (en) | 1998-06-10 | 2003-04-22 | Monsanto/G.D. Searle | Pyrrolo[2,1-c][1,2,4] thiadiazoles and Pyrollo[2,1-c][1,12,4]oxadiazoles useful as nitric oxide synthase inhibitors |
| AU1704100A (en) | 1998-09-08 | 2000-03-27 | Monsanto Company | Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors |
| AU1308400A (en) * | 1998-10-30 | 2000-05-22 | G.D. Searle & Co. | Novel amino acid heterocyclic amide derivatives useful as nitric oxide synthase inhibitors |
| AU2847200A (en) * | 1999-01-27 | 2000-08-18 | G.D. Searle & Co. | Novel hydroxyamidino carboxylate derivatives useful as nitric oxide synthase inhibitors |
| AU4329000A (en) * | 1999-04-19 | 2000-11-02 | G.D. Searle & Co. | Novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors |
| AU6216900A (en) * | 1999-07-15 | 2001-02-05 | Monsanto Company | Oligomeric amino acid derivatives useful as nitric oxide synthase inhibitors |
| US6403830B2 (en) | 2000-03-24 | 2002-06-11 | Pharmacia Corporation | Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| US6956131B2 (en) | 2000-04-13 | 2005-10-18 | Pharmacia Corporation | 2-amino-3, 4 heptenoic compounds useful as nitric oxide synthase inhibitors |
| US6545170B2 (en) | 2000-04-13 | 2003-04-08 | Pharmacia Corporation | 2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| AR032318A1 (es) * | 2000-04-13 | 2003-11-05 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa |
| AR030416A1 (es) | 2000-04-13 | 2003-08-20 | Pharmacia Corp | COMPUESTO DERIVADO HALOGENADO DEL ACIDO 2-AMINO-3,4 HEPTENOICO, COMPOSICION FARMACEUTICA QUE LO COMPRENDE Y SU USO EN LA FABRICACION DE UN MEDICAMENTO uTIL COMO INHIBIDOR DE LA OXIDO NITRICO SINTETASA |
| AR034120A1 (es) * | 2000-04-13 | 2004-02-04 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-4,5 heptenoico, composicion farmaceutica que lo comprende y el uso de dicho compuesto y dicha composicion en la fabricacion de un medicamento para inhibir o modular la sintesis de acido nitrico |
| US6787668B2 (en) | 2000-04-13 | 2004-09-07 | Pharmacia Corporation | 2-amino-4,5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| AR030741A1 (es) * | 2000-09-15 | 2003-09-03 | Pharmacia Corp | Derivados de los acidos 2-amino-2-alquil-5-heptenoico y - heptinoico utiles como inhibidores de oxido nitrico sintetasa |
| TWI243164B (en) * | 2001-02-13 | 2005-11-11 | Aventis Pharma Gmbh | Acylated indanyl amines and their use as pharmaceuticals |
| US7012098B2 (en) * | 2001-03-23 | 2006-03-14 | Pharmacia Corporation | Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| US20030109522A1 (en) * | 2001-09-24 | 2003-06-12 | Manning Pamela T. | Ophthalmologic treatment methods using selective iNOS inhibitors |
| JP2006500342A (ja) * | 2002-08-02 | 2006-01-05 | ファルマシア・コーポレーション | 胃腸の状態の治療および予防方法 |
| NZ538184A (en) * | 2002-08-23 | 2008-02-29 | Pharmacia Corp | Crystalline solid form of (2S-5Z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid 1.5 hydrochloride |
| EP1741709A1 (de) * | 2005-06-28 | 2007-01-10 | Sanofi-Aventis Deutschland GmbH | Heteroaryl substituierte Amide mit gesättigtem Linker, und deren Verwendung als Pharmaka |
| WO2016114818A1 (en) * | 2015-01-14 | 2016-07-21 | The Medicines Company | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3505555A1 (de) * | 1985-02-18 | 1986-09-11 | Behringwerke Ag, 3550 Marburg | Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel |
| US5196450A (en) * | 1985-12-19 | 1993-03-23 | Merrell Dow Pharmaceuticals Inc. | Method of inhibiting protozoal growth |
| AU619613B2 (en) * | 1988-11-10 | 1992-01-30 | Merrell Dow Pharmaceuticals Inc. | Lactamimides in the treatment of drug-resistant protozoal infections |
| US5028627A (en) * | 1989-09-13 | 1991-07-02 | Cornell Research Foundation, Inc. | Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| US5059712A (en) * | 1989-09-13 | 1991-10-22 | Cornell Research Foundation, Inc. | Isolating aminoarginine and use to block nitric oxide formation in body |
| GB8929076D0 (en) * | 1989-12-22 | 1990-02-28 | Scras | Treatment of shock by blocking agents of edrf effect or formation |
| CA2036770C (en) * | 1990-02-26 | 2003-09-09 | Jeffrey P. Whitten | Inhibitors of nitric oxide biosynthesis |
| US5273875A (en) * | 1991-03-22 | 1993-12-28 | Cornell Research Foundation, Inc. | N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
| US5132453A (en) * | 1991-03-22 | 1992-07-21 | Cornell Research Foundation, Inc. | N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
| GB9127376D0 (en) * | 1991-12-24 | 1992-02-19 | Wellcome Found | Amidino derivatives |
| US5296466A (en) * | 1992-02-19 | 1994-03-22 | Board Of Regents, The University Of Texas System | Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein |
| US5281627A (en) * | 1992-05-28 | 1994-01-25 | Cornell Research Foundation, Inc. | Substituted arginines and substituted homoarginines and use thereof |
| AU5704594A (en) * | 1992-12-18 | 1994-07-19 | Wellcome Foundation Limited, The | Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors |
| GB9312761D0 (en) * | 1993-06-21 | 1993-08-04 | Wellcome Found | Amino acid derivatives |
| US5424447A (en) * | 1993-07-07 | 1995-06-13 | The Medical College Of Wisconsin Research Foundation, Inc. | Heme binding compounds and use thereof |
| DE69431194T2 (de) * | 1993-10-21 | 2002-12-12 | G.D. Searle & Co., Chicago | Amidino-derivate nützlich als no synthase-hemmer |
| US5364881A (en) * | 1993-11-15 | 1994-11-15 | The Medical College Of Wisconsin Research Foundation, Inc. | S-alkyl-isothioureido-amino acids and use thereof |
| US5362744A (en) * | 1993-11-22 | 1994-11-08 | Warner-Lambert Company | Tetrazole-substituted urea acat inhibitors |
| AU2190895A (en) * | 1994-03-24 | 1995-10-09 | G.D. Searle & Co. | Amidino derivatives useful as nitric oxide synthase inhibitors |
| WO1996006076A1 (en) * | 1994-08-18 | 1996-02-29 | Chugai Seiyaku Kabushiki Kaisha | Amino acid derivative having nitrogen monoxide synthetase inhibitor activity |
| US5684008A (en) * | 1994-11-09 | 1997-11-04 | G. D. Searle & Co. | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
-
1994
- 1994-11-09 US US08/336,596 patent/US5684008A/en not_active Expired - Fee Related
-
1995
- 1995-11-08 NZ NZ296019A patent/NZ296019A/en not_active IP Right Cessation
- 1995-11-08 RU RU97109847/04A patent/RU2152927C1/ru not_active IP Right Cessation
- 1995-11-08 PT PT95937674T patent/PT790987E/pt unknown
- 1995-11-08 DE DE69522703T patent/DE69522703T2/de not_active Expired - Fee Related
- 1995-11-08 KR KR1019970703106A patent/KR970707107A/ko not_active Ceased
- 1995-11-08 CN CN95197112A patent/CN1065531C/zh not_active Expired - Fee Related
- 1995-11-08 AU AU39711/95A patent/AU696527B2/en not_active Ceased
- 1995-11-08 DE DE69535148T patent/DE69535148T2/de not_active Expired - Fee Related
- 1995-11-08 ES ES95937674T patent/ES2164164T3/es not_active Expired - Lifetime
- 1995-11-08 JP JP51609696A patent/JP3278165B2/ja not_active Expired - Fee Related
- 1995-11-08 DK DK95937674T patent/DK0790987T3/da active
- 1995-11-08 DK DK01104598T patent/DK1113011T3/da active
- 1995-11-08 EP EP01104598A patent/EP1113011B1/de not_active Expired - Lifetime
- 1995-11-08 CA CA002203237A patent/CA2203237C/en not_active Expired - Fee Related
- 1995-11-08 AT AT95937674T patent/ATE205484T1/de not_active IP Right Cessation
- 1995-11-08 EP EP95937674A patent/EP0790987B1/de not_active Expired - Lifetime
- 1995-11-08 US US08/817,971 patent/US5854251A/en not_active Expired - Fee Related
- 1995-11-08 ES ES01104598T patent/ES2269240T3/es not_active Expired - Lifetime
- 1995-11-08 AT AT01104598T patent/ATE334974T1/de not_active IP Right Cessation
- 1995-11-08 BR BR9509629A patent/BR9509629A/pt not_active IP Right Cessation
- 1995-11-08 PT PT01104598T patent/PT1113011E/pt unknown
- 1995-11-08 WO PCT/US1995/014001 patent/WO1996015120A1/en not_active Ceased
-
1998
- 1998-10-05 US US09/166,036 patent/US5919787A/en not_active Expired - Fee Related
-
1999
- 1999-03-12 US US09/267,266 patent/US6169089B1/en not_active Expired - Fee Related
-
2000
- 2000-10-13 US US09/687,350 patent/US6410542B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1113011B1 (de) | 2006-08-02 |
| DK1113011T3 (da) | 2006-11-27 |
| HK1036802A1 (en) | 2002-01-18 |
| NZ296019A (en) | 1998-09-24 |
| RU2152927C1 (ru) | 2000-07-20 |
| DK0790987T3 (da) | 2001-11-12 |
| JP3278165B2 (ja) | 2002-04-30 |
| CA2203237A1 (en) | 1996-05-23 |
| CN1065531C (zh) | 2001-05-09 |
| US6410542B1 (en) | 2002-06-25 |
| US5684008A (en) | 1997-11-04 |
| AU696527B2 (en) | 1998-09-10 |
| EP0790987A1 (de) | 1997-08-27 |
| DE69522703T2 (de) | 2002-07-11 |
| US5854251A (en) | 1998-12-29 |
| ES2269240T3 (es) | 2007-04-01 |
| KR970707107A (ko) | 1997-12-01 |
| EP0790987B1 (de) | 2001-09-12 |
| AU3971195A (en) | 1996-06-06 |
| US6169089B1 (en) | 2001-01-02 |
| CA2203237C (en) | 2008-06-03 |
| ATE334974T1 (de) | 2006-08-15 |
| PT790987E (pt) | 2002-02-28 |
| JPH10508847A (ja) | 1998-09-02 |
| BR9509629A (pt) | 1998-01-06 |
| DE69535148T2 (de) | 2007-07-05 |
| PT1113011E (pt) | 2006-11-30 |
| US5919787A (en) | 1999-07-06 |
| DE69522703D1 (de) | 2001-10-18 |
| CN1171104A (zh) | 1998-01-21 |
| EP1113011A1 (de) | 2001-07-04 |
| WO1996015120A1 (en) | 1996-05-23 |
| DE69535148D1 (de) | 2006-09-14 |
| ES2164164T3 (es) | 2002-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE205484T1 (de) | Aminotetrazol-derivate verwendbar als stickstoff- oxid-synthase inhibitoren | |
| PT1140851E (pt) | 4-oxo-1,4-di-hidro-3-quinolinacarboxamidas como agentes antivirais | |
| DE69720773D1 (de) | SAUERSTOFF ODER SCHWEFEL ENTHALTENDE 5-GLIEDRIGE HETEROAROMATISHE DERIVATIVE ALS FACTOR Xa HEMMER | |
| NO931433D0 (no) | 4,1-benzoksazepinderivater og deres anvendelse | |
| NO942452D0 (no) | Amid- og ureaderivater med antihyperkolesteremisk aktivitet, deres fremstilling og terapeutiske anvendelser | |
| GB2262093B (en) | Piperazine derivatives | |
| DE69120581D1 (de) | 1,8-Naphthyridin-2-on-Derivate | |
| DE69122941D1 (de) | Piperazinderivate | |
| DE69725585D1 (de) | Phenylalkylcarbonsäure-derivate | |
| IS3828A (is) | Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar | |
| ES2102327A1 (es) | Nuevos derivados de 2,2,6,6-tetrametilpiperidina para utilizarse como agentes estabilizantes para materiales organicos contra la luz, el calor, y la oxidacion. n | |
| DE69429185D1 (de) | Imidazolidinon-derivate, deren säure-additionssalze und mittel gegen senile demenz | |
| NO972731D0 (no) | Thiazolidinonforbindelser eller middel inneholdende disse for å behandle eller forhindre angina pectoris |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |